Biosino Bio-Technology & Science Inc revenue jumped on 12.1%
18/03/2017 • About Biosino Bio-Technology & Science Inc (
$8247) • By InTwits
Biosino Bio-Technology & Science Inc reported FY2016 financial results today. Overall the company's long term financial model is characterised by the following facts: EBITDA Margin is declining: in FY2016 vs. 7.9% in FY2015 vs. 18.3% in FY2012.
Below you can find a comprehensive analysis of the key data driving the company's performance and stock price.
Biosino Bio-Technology & Science Inc ($8247) key annual financial indicators
| mln. CNY | 2012 | 2013 | 2014 | 2015 | 2016 | 2016/2015 |
|---|
P&L
|
|---|
| Revenue | 210.1 | 234.5 | 265.3 | 290.4 | 325.4 | 12.1% |
| Gross Profit | 116.5 | 127.8 | 131.8 | 139.4 | | -100.0% |
| SG&A | 77.1 | 92.2 | 97.9 | 116.2 | | -100.0% |
| EBITDA | 38.4 | 40.2 | 35.5 | 23.1 | | -100.0% |
| Net Income | 17.2 | 9.1 | 8.5 | 0.6 | 16.0 | 2,617.7% |
Balance Sheet
|
|---|
| Cash | 43.2 | 69.0 | 54.8 | 45.1 | | -100.0% |
| Short Term Debt | 0.0 | 0.0 | 1.0 | 0.0 | | |
| Long Term Debt | 0.0 | 0.0 | 0.0 | 0.0 | | |
Cash flow
|
|---|
| Capex | 26.6 | 11.5 | 18.3 | 15.0 | | -100.0% |
Ratios
|
|---|
| Revenue growth | 14.1% | 11.6% | 13.2% | 9.4% | 12.1% | |
| EBITDA growth | -16.8% | 4.7% | -11.7% | -35.0% | | |
| Gross Margin | 55.5% | 54.5% | 49.7% | 48.0% | | -48.0% |
| EBITDA Margin | 18.3% | 17.1% | 13.4% | 7.9% | 0.0% | -7.9% |
| Net Income Margin | 8.2% | 3.9% | 3.2% | 0.2% | 4.9% | 4.7% |
| SG&A, % of revenue | 36.7% | 39.3% | 36.9% | 40.0% | | -40.0% |
| CAPEX, % of revenue | 12.6% | 4.9% | 6.9% | 5.1% | | -5.1% |
| ROIC | 6.8% | 7.1% | 5.2% | 1.0% | | -1.0% |
| ROE | 5.9% | 3.1% | 2.9% | 0.2% | | -0.2% |
| Net Debt/EBITDA | -1.1x | -1.7x | -1.5x | -2.0x | | 2.0x |
Revenue and profitability
Biosino Bio-Technology & Science Inc's Revenue jumped on 12.1%.
Net Income marign increased on 4.7 pp from 0.20% to 4.9% in FY2016.
Appendix 1: Peers in Healthcare-Products
Below we provide Biosino Bio-Technology & Science Inc benchmarking against other companies in Healthcare-Products industry for the last 5 years. We show data for the top-5 companies by key financial metric together with the median value for all the companies in the industry.
Top companies by Revenue growth, %
| Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| Vitop Bioenergy Holdings Ltd ($1178) | | -3.2% | -27.3% | 92.4% | 281.7% |
| Beijing Chunlizhengda Medical Instruments Co Ltd ($1858) | 22.2% | 12.8% | 21.8% | 32.0% | |
| China Medical System Holdings Ltd ($867) | 30.8% | 26.5% | 31.0% | 20.7% | |
| Shandong Weigao Group Medical Polymer Co Ltd ($1066) | 16.0% | 25.1% | 14.4% | 12.1% | |
| BBI Life Sciences Corp ($1035) | 16.4% | 18.0% | 15.1% | 11.5% | |
| |
|---|
| Median (16 companies) | 16.4% | 15.4% | 10.8% | 5.2% | -14.8% |
|---|
| Biosino Bio-Technology & Science Inc ($8247) | | 11.6% | 13.2% | 9.4% | 12.1% |
Top companies by Gross margin, %
| Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| Lifetech Scientific Corp ($1302) | 80.1% | 81.6% | 81.4% | 81.1% | |
| PW Medtech Group Ltd ($1358) | 66.0% | 67.9% | 72.8% | 75.1% | |
| Golden Meditech Holdings Ltd ($801) | 69.1% | 69.8% | 70.2% | 72.8% | 45.8% |
| Beijing Chunlizhengda Medical Instruments Co Ltd ($1858) | 71.6% | 72.1% | 73.8% | 68.6% | |
| Microport Scientific Corp ($853) | 83.6% | 81.0% | 68.5% | 67.2% | |
| |
|---|
| Median (16 companies) | 50.0% | 50.8% | 49.1% | 50.6% | 21.7% |
|---|
| Biosino Bio-Technology & Science Inc ($8247) | 55.5% | 54.5% | 49.7% | 48.0% | |
Top companies by EBITDA margin, %
| Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| PW Medtech Group Ltd ($1358) | 44.2% | 30.6% | 41.6% | 48.6% | |
| Lifetech Scientific Corp ($1302) | 31.6% | 24.5% | 23.4% | 33.1% | |
| China Medical System Holdings Ltd ($867) | 34.5% | 32.4% | 39.4% | 32.3% | |
| Hengan International Group Co Ltd ($1044) | 27.4% | 25.3% | 25.3% | 28.0% | |
| Shandong Weigao Group Medical Polymer Co Ltd ($1066) | 28.5% | 28.0% | 29.0% | 27.8% | |
| |
|---|
| Median (16 companies) | 26.6% | 24.9% | 13.2% | 11.1% | -38.3% |
|---|
| Biosino Bio-Technology & Science Inc ($8247) | 18.3% | 17.1% | 13.4% | 7.9% | |
Top companies by CAPEX/Revenue, %
| Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| Lifetech Scientific Corp ($1302) | 0.0% | 16.5% | 0.0% | 70.0% | |
| PW Medtech Group Ltd ($1358) | 14.8% | 22.3% | 30.2% | 42.1% | |
| Arts Optical International Hldgs ($1120) | 14.0% | 4.5% | 14.0% | 29.9% | |
| Golden Meditech Holdings Ltd ($801) | 12.7% | 51.2% | 27.3% | 26.1% | 56.4% |
| BBI Life Sciences Corp ($1035) | 23.6% | 6.7% | 6.4% | 20.0% | |
| |
|---|
| Median (16 companies) | 5.2% | 6.6% | 5.7% | 7.2% | 1.7% |
|---|
| Biosino Bio-Technology & Science Inc ($8247) | 12.6% | 4.9% | 6.9% | 5.1% | |
Top companies by ROIC, %
| Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| Lifetech Scientific Corp ($1302) | 17.5% | 15.9% | 21.2% | 32.9% | |
| China Medical System Holdings Ltd ($867) | 19.4% | 20.2% | 27.4% | 20.5% | |
| Hengan International Group Co Ltd ($1044) | 19.5% | 14.9% | 14.0% | 16.4% | |
| Beijing Chunlizhengda Medical Instruments Co Ltd ($1858) | 22.2% | 20.9% | 21.0% | 12.1% | |
| Shandong Weigao Group Medical Polymer Co Ltd ($1066) | 10.5% | 11.7% | 12.8% | 11.8% | |
| |
|---|
| Median (16 companies) | 10.3% | 8.4% | 5.1% | 6.2% | -4.1% |
|---|
| Biosino Bio-Technology & Science Inc ($8247) | 6.8% | 7.1% | 5.2% | 1.0% | |
Top companies by Net Debt / EBITDA
| Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| Microport Scientific Corp ($853) | -1.0x | -2.8x | | 4.3x | |
| Techcomp Holdings Ltd ($1298) | 4.3x | 3.6x | 2.7x | 3.0x | |
| Hengan International Group Co Ltd ($1044) | 1.4x | 1.7x | 1.8x | 1.7x | |
| China Medical System Holdings Ltd ($867) | -0.4x | -0.2x | 0.2x | -0.0x | |
| PW Medtech Group Ltd ($1358) | -1.2x | -7.5x | -0.3x | -1.1x | |
| |
|---|
| Median (11 companies) | -1.1x | -1.4x | -1.5x | -1.1x | 0.9x |
|---|
| Biosino Bio-Technology & Science Inc ($8247) | -1.1x | -1.7x | -1.5x | -2.0x | |
